Evidence map›Paper›PMID 34299623›Full record

ArticleMolecules (Basel, Switzerland)2021

Oxyresveratrol-Loaded PLGA Nanoparticles Inhibit Oxygen Free Radical Production by Human Monocytes: Role in Nanoparticle Biocompatibility.

Marta Donini, Salvatore Calogero Gaglio, Carlo Laudanna, Massimiliano Perduca, Stefano Dusi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Marta DoniniDepartment of Medicine, Section of General Pathology, University of Verona, Strada Le Grazie 8, 37134 Verona, Italy.
Salvatore Calogero GaglioDepartment of Biotechnology, University of Verona, Strada Le Grazie 15, 37134 Verona, Italy.
Carlo LaudannaDepartment of Medicine, Section of General Pathology, University of Verona, Strada Le Grazie 8, 37134 Verona, Italy.
Massimiliano PerducaDepartment of Biotechnology, University of Verona, Strada Le Grazie 15, 37134 Verona, Italy.ORCID 0000-0001-8291-0523
Stefano DusiDepartment of Medicine, Section of General Pathology, University of Verona, Strada Le Grazie 8, 37134 Verona, Italy.ORCID 0000-0001-9753-5076
University of Verona · IT

Funding

University of Verona FUR (Fondo Unico della Ricerca)
6 · The paper itself

Abstract

Oxyresveratrol, a polyphenol extracted from the plant

Indexed as

AntioxidantsArtocarpusBiocompatible MaterialsCells, CulturedFree RadicalsHumansMonocytesNanoparticlesOxygenPlant ExtractsPolylactic Acid-Polyglycolic Acid CopolymerReactive Oxygen SpeciesStilbenesAntioxidantsBiocompatible MaterialsFree RadicalsOxygenPlant ExtractsPolylactic Acid-Polyglycolic Acid Copolymerpuag-haadReactive Oxygen SpeciesStilbenesmonocytesoxyresveratrolPLGA nanoparticlesROSβ-glucan

Identifiers

PMID34299623
PMCPMC8305861
OpenAlexW3184668307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.